Christopher William Walters - 27 Nov 2023 Form 4 Insider Report for AVANTAX, INC.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
29 Nov 2023, 15:41:23 UTC
Prior SEC filing
25 May 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tabitha T. Bailey, as Attorney-in-Fact for Christopher W. Walters

Key filing fact

Christopher William Walters filed Form 4 for AVANTAX, INC. on 29 Nov 2023.

Key facts

  • This page summarizes Christopher William Walters's Form 4 filing for AVANTAX, INC..
  • 12 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 29 Nov 2023, 15:41.

Change

  • Previous filing in this sequence was filed on 25 May 2023.
  • Current net transaction value: -$22,551,854.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVTA transaction

Common Stock

Disposed to Issuer

Transaction value
$9,207,146
Shares
-354,121
Change %
-100%
Price
$26.00
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F2
AVTA transaction

Common Stock

Award

Transaction value
$0
Shares
+180,832
Change %
Price
$0.000000
Shares after
180,832
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F3
AVTA transaction

Common Stock

Disposed to Issuer

Transaction value
$4,701,632
Shares
-180,832
Change %
-100%
Price
$26.00
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F4
AVTA transaction

Common Stock

Award

Transaction value
$0
Shares
+203,619
Change %
Price
$0.000000
Shares after
203,619
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F5
AVTA transaction

Common Stock

Disposed to Issuer

Transaction value
$5,294,094
Shares
-203,619
Change %
-100%
Price
$26.00
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F4
AVTA transaction

Common Stock

Award

Transaction value
$0
Shares
+128,807
Change %
Price
$0.000000
Shares after
128,807
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F6
AVTA transaction

Common Stock

Disposed to Issuer

Transaction value
$3,348,982
Shares
-128,807
Change %
-100%
Price
$26.00
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Footnotes
F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AVTA transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-165,782
Change %
-100%
Price
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
165,782
Exercise price
$23.36
Footnotes
F1, F7, F8
AVTA transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-104,477
Change %
-100%
Price
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
104,477
Exercise price
$11.30
Footnotes
F1, F7, F9
AVTA transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-216,666
Change %
-100%
Price
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
216,666
Exercise price
$15.00
Footnotes
F1, F7, F10
AVTA transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-135,746
Change %
-100%
Price
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
135,746
Exercise price
$17.68
Footnotes
F1, F7, F11
AVTA transaction Derivative

Stock Option (Right to Buy)

Disposed to Issuer

Transaction value
Shares
-102,604
Change %
-100%
Price
Shares after
0
Date
27 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
102,604
Exercise price
$25.34
Footnotes
F1, F7, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Christopher William Walters is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 12 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent.

Footnote F2

Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings).

Footnote F3

On January 4, 2021, the reporting person was granted 116,666 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 155% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.

Footnote F4

Pursuant to the terms of the Merger Agreement, at the Effective Time, these PSUs were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of Common Stock underlying such PSU multiplied by (ii) $26.00 (less any required tax withholdings).

Footnote F5

On January 3, 2022, the reporting person was granted 169,683 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 120% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.

Footnote F6

On January 3, 2023, the reporting person was granted 118,389 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 109% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.

Footnote F7

Pursuant to the terms of the Merger Agreement, at the Effective Time, these options to purchase shares of Common Stock ("Stock Options") automatically vested (if unvested) and were canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of $26.00 over the per-share exercise price for such Stock Option multiplied by (ii) the total number of shares of Common Stock underlying such Stock Option, subject to any required tax withholding in accordance with the terms of the Merger Agreement.

Footnote F8

The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on January 30, 2023.

Footnote F9

The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on May 21, 2023.

Footnote F10

The option vests equally over a 3-year period, on each anniversary of the grant date, such that the option would fully vest on January 4, 2024.

Footnote F11

The option vests equally over a 3-year period, on each anniversary of the grant date, such that the option would fully vest on January 3, 2025.

Footnote F12

The option vests equally over a 3-year period, on each anniversary of the grant date, such that the option would fully vest on January 3, 2026.

SEC remarks

Exhibit List: Exhibit 24-Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .